Bio-IT World. The recently published results of the first round of the Assemblathon offer several important lessons in tackling such projects, according to co-organizer Ian Korf.
Bio-IT World. The recently published results of the first round of the Assemblathon offer several important lessons in tackling such projects, according to co-organizer Ian Korf.
Clinical Sequencing News. New York's Mount Sinai Hospital is planning to launch next year a series of targeted sequencing-based diagnostic tests on the Pacific Biosciences RS.
In Sequence. Millennium Science will be distributing Pacific Biosciences' PacBio RS single-molecule sequencer in Australia and New Zealand, the companies said this week.
In Sequence. The US Department of Energy's Joint Genome Institute gears up to produce more than 47 trillion bases of DNA sequence in 2012
GenomeWeb. Expression Analysis, which provides sequencing services on the Pacific Biosciences platform, recently presented internally generated data using PacBio's new C2 chemistry that will be launched more...
The New York Times. Bacterial genome sequencing offers latest tool against diseases.
Fortune Magazine. Hugh Martin named #1 Start-up CEO
Lab Dish - A CSHL News Blog. At CSHL’s Woodbury Genome Center a decade ago, it took 12 technicians working in two shifts and six “first generation” sequencing machines to sequence 70 million bases of DNA—repeats of A, T, G, C—in a single month.
GenomeWeb. OICR plans to validate the machine and develop a framework for sequencing patient tumors that can help physicians make informed decisions about treatments or clinical trial placements.
Xconomy. Scary headlines about the E.coli outbreak in Germany have faded, but scientists are still looking to learn about the DNA sequence of this new bacterial invader, and how it evolved to become deadly.
New York Times. With his boundless energy and unvarying outfit of shorts, sandals and a white polo shirt, Eric E. Schadt, the chief scientific officer of DNA sequencer manufacturer Pacific Biosciences, is considered a brilliant rebel in the field of genomics.
Xconomy. This new arrangement is being set up as a bi-coastal collaboration between Menlo Park, CA-based PacBio (NASDAQ: PACB) and Mt. Sinai, in which Schadt will divide time between academia and industry.
Bio-IT World. Kevin Davies interviews members of the PacBio informatics team about the open-source software created for the PacBio RS.
Bloomberg BusinessWeek. Pacific Biosciences’ technology may finally fulfill the dream of gene sequencing.
Xconomy. National Biotechnology Editor Luke Timmerman visited PacBio as the company prepared for commercial shipping.
BioInform. By making its SMRT Analysis suite available under an open source license, the company hopes to "accelerate the development of software and informatics tools for third-generation sequence data."
Esquire Magazine.
Can Eric Schadt and the PacBio team help change the way we view biology?
BusinessWeek. Genomics startups like PacBio are helping to reshape the pharmaceutical sector and other industries from agriculture to energy.
Technology Review. PacBio made the TR50 list of most innovative companies, recognized for contributions to advancing in pathogen detection.
Medtech Executive. MedTech Executive interviewed PacBio CEO Hugh Martin about his leadership and the launch of the PacBio RS.
Science. CSO Dr. Eric Schadt penned this perspectives piece for the 10th Anniversary of the Human Genome Publication.
In Sequence. Several early-access users of the PacBio RS reported at AGBT how the single-molecule real-time sequencing technology has been performing in their hands.
In Sequence. Pacific Biosciences has partnered with 13 more companies and organizations on products and services upstream and downstream of its sequencing platform.
Drug Discovery News. CSO Dr. Eric Schadt discusses the recent project to rapidly sequence the Haitian cholera pathogen.
CBS Evening News with Katie Couric. Hugh Martin demonstrates why full disclosure doesn't have to be bad for business.